The national biomarker development alliance: confronting the poor productivity of biomarker research and development

Publication and Reporting of Test Accuracy Studies Registered in ClinicalTrials.gov

(2014) D. A. Korevaar et al.   CLINICAL CHEMISTRY

Clinical Interpretation and Implications of Whole-Genome Sequencing

(2014) Frederick E. Dewey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rescuing US biomedical research from its systemic flaws

(2014) B. Alberts et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Data sharing policy design for consortia: challenges for sustainability

(2014) Jane Kaye et al.   Genome Medicine

The Next-Generation Sequencing Revolution and Its Impact on Genomics

(2013) Daniel C. Koboldt et al.   CELL

miRNAs and long noncoding RNAs as biomarkers in human diseases

(2013) Katrien Van Roosbroeck et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Reforming Biobank Consent Policy: A Necessary Move Away from Broad Consent Toward Dynamic Consent

(2013) Dorit T. Stein et al.   Genetic Testing and Molecular Biomarkers

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Comment on "ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models"

(2013) K. Veeraraghavalu et al.   SCIENCE

Regulatory and Reimbursement Innovation

(2013) R. A. Lindor et al.   Science Translational Medicine

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

(2013) Elisabeth Drucker et al.   EPMA Journal

Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures

(2012) S. E. Kern   CANCER RESEARCH

Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy

(2012) S. M. Hewitt et al.   CLINICAL CANCER RESEARCH

Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development

(2012) G. Poste et al.   CLINICAL CANCER RESEARCH

Systematic Reviews of Studies Quantifying the Accuracy of Diagnostic Tests and Markers

(2012) J. B. Reitsma et al.   CLINICAL CHEMISTRY

Pharmacogenomics Knowledge for Personalized Medicine

(2012) M Whirl-Carrillo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

An informatics approach to analyzing the incidentalome

(2012) Jonathan S. Berg et al.   GENETICS IN MEDICINE

Raise standards for preclinical cancer research

(2012) C. Glenn Begley et al.   NATURE

Cancer biomarkers: selecting the right drug for the right patient

(2012) Gary J. Kelloff et al.   NATURE REVIEWS DRUG DISCOVERY

Misconduct accounts for the majority of retracted scientific publications

(2012) F. C. Fang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards

(2012) George Poste   TRENDS IN MOLECULAR MEDICINE

International Approaches to Advancing Biospecimen Science

(2011) H. M. Moore et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Bring on the biomarkers

(2011) George Poste   NATURE

Performance comparison of whole-genome sequencing platforms

(2011) Hugo Y K Lam et al.   NATURE BIOTECHNOLOGY

Biomarker studies: a call for a comprehensive biomarker study registry

(2011) Fabrice Andre et al.   Nature Reviews Clinical Oncology

Believe it or not: how much can we rely on published data on potential drug targets?

(2011) Florian Prinz et al.   NATURE REVIEWS DRUG DISCOVERY

The molecular pathology of cancer

(2010) Timothy J. R. Harris et al.   Nature Reviews Clinical Oncology

Meeting the Governance Challenges of Next-Generation Biorepository Research

(2010) S. M. Fullerton et al.   Science Translational Medicine

Editorial Policies and Publication Bias

(2009) Lakshmi Sridharan et al.   ARCHIVES OF INTERNAL MEDICINE

Sources of Bias in Specimens for Research About Molecular Markers for Cancer

(2009) David F. Ransohoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Reporting Bias in Diagnostic and Prognostic Studies: Time for Action

(2008) N. Rifai et al.   CLINICAL CHEMISTRY